Geron Corporation Receives Milestone Payment From Exeter Life Sciences, Inc.

Published: Apr 15, 2008

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) announced that is has received a milestone payment of $1.5 million from Exeter Life Sciences, Inc. as a result of the final Risk Assessment released by the U.S. Food and Drug Administration addressing food products made from cloned animals or their progeny. The Risk Assessment, available at, concluded that consumption of such food products poses no greater risk than consumption of food products from animals produced by conventional breeding methods.

Back to news